Open access
2,485
Views
1
CrossRef citations to date
0
Altmetric
Drug Profile
Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis
Stephanie R Harrisona NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK;b Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
https://orcid.org/0000-0002-7465-2621View further author information
Helena Marzo-Ortegaa NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK;b Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UKCorrespondence[email protected]
https://orcid.org/0000-0002-9683-3407View further author information
Pages 1059-1071
|
Received 03 Jun 2021, Accepted 17 Aug 2021, Published online: 26 Aug 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.